Semi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseases Post author:admin Post published: March 15, 2025 Post category:uncategorized A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. You Might Also Like Rising health costs push some middle-aged adults to skip the doc until Medicare March 23, 2026 GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies October 23, 2025 New NIA grant advances tools for dementia caregiving October 15, 2025
GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies October 23, 2025